Federal Register of Legislation - Australian Government

Primary content

PB 104 of 2022 Determinations/Health as made
This instrument amends the National Health (Listed Drugs on F1 or F2) Determination 2021 by adding three new drugs, burosumab, cemiplimab and tepotinib, to F1.
Administered by: Health and Aged Care
Registered 31 Oct 2022
Tabling HistoryDate
Tabled HR07-Nov-2022
Tabled Senate21-Nov-2022
Date of repeal 08 Mar 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Enabled by
Authoritative version National Health Act 1953
C1953A00095No. 95, 1953